CHATFIELD HEALTH CARE — All Prescriptions & Medications — Page 3
Practice Code: H85047 | LONDON, SW11 3UJ
Showing results 101-150 of 603
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Memantine hydrochloride | 340 | 5,702 | £969 | +2.9% ▲ |
| Duloxetine hydrochloride | 337 | 9,413 | £911 | -47.0% ▼ |
| Gabapentin | 331 | 38.1K | £1.3K | -66.9% ▼ |
| Latanoprost | 330 | 6,565 | £2.7K | -32.0% ▼ |
| 330 | 48.2K | £3.1K | +52.6% ▲ | |
| Hydroxocobalamin | 329 | 467 | £1.0K | -31.6% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 328 | 31.8K | £1.5K | +82.5% ▲ |
| 325 | 33.9K | £1.2K | +281.7% ▲ | |
| Atenolol | 324 | 9,506 | £222 | -46.3% ▼ |
| Escitalopram | 322 | 12.2K | £808 | +13.1% ▲ |
| Sumatriptan succinate | 321 | 3,532 | £4.7K | -9.4% ▼ |
| Sacubitril/valsartan | 311 | 8,981 | £14.7K | +29.9% ▲ |
| Montelukast | 311 | 8,316 | £394 | -54.6% ▼ |
| Betamethasone valerate | 310 | 28.3K | £1.5K | -19.5% ▼ |
| Aciclovir | 302 | 12.1K | £583 | +103.0% ▲ |
| Hepatitis A | 299 | 299 | £6.0K | +293.8% ▲ |
| 297 | 192.8K | £2.9K | +12.6% ▲ | |
| Melatonin | 292 | 16.2K | £5.0K | -12.2% ▼ |
| Tirzepatide | 291 | 341 | £33.0K | +49.8% ▲ |
| Estradiol with progestogen | 290 | 10.7K | £9.2K | -14.9% ▼ |
| Estriol | 290 | 5,625 | £4.2K | +36.3% ▲ |
| Warfarin sodium | 289 | 12.8K | £445 | -38.7% ▼ |
| Vitamin B compound | 286 | 11.0K | £347 | +105.3% ▲ |
| Typhoid | 283 | 283 | £2.9K | +214.3% ▲ |
| Hepatitis B | 277 | 277 | £3.3K | +2,517.5% ▲ |
| Paroxetine hydrochloride | 274 | 8,424 | £355 | +46.8% ▲ |
| Letrozole | 271 | 7,984 | £2.1K | +45.1% ▲ |
| Estradiol | 267 | 7,017 | £4.0K | -1.0% vs avg |
| Tramadol hydrochloride | 265 | 20.7K | £1.1K | -63.0% ▼ |
| Hepatitis A/hepatitis B | 253 | 253 | £7.8K | +1,395.8% ▲ |
| Ibuprofen | 249 | 23.6K | £635 | -51.0% ▼ |
| Mometasone furoate | 248 | 283 | £2.2K | -38.2% ▼ |
| Carbimazole | 247 | 6,577 | £377 | +118.7% ▲ |
| Aripiprazole | 242 | 4,704 | £617 | -4.9% ▼ |
| Tadalafil | 237 | 5,506 | £1.4K | +39.4% ▲ |
| Hydroxychloroquine sulfate | 237 | 9,635 | £642 | +22.4% ▲ |
| Hydralazine hydrochloride | 233 | 4,970 | £302 | +452.2% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 232 | 17.9K | £1.2K | +2.7% ▲ |
| Methylphenidate hydrochloride | 230 | 11.3K | £8.2K | -10.9% ▼ |
| Irbesartan | 228 | 7,287 | £318 | -6.4% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 225 | 26.6K | £1.5K | +48.8% ▲ |
| Insulin glargine | 220 | 1,129 | £9.8K | -22.5% ▼ |
| 220 | 24.4K | £967 | +221.2% ▲ | |
| Cetirizine hydrochloride | 219 | 22.8K | £1.2K | -56.2% ▼ |
| Lactulose | 218 | 123.5K | £1.2K | -33.8% ▼ |
| Clarithromycin | 214 | 4,372 | £923 | -12.8% ▼ |
| Nebivolol | 213 | 3,945 | £676 | +100.9% ▲ |
| Ferrous sulfate | 213 | 12.4K | £439 | -58.6% ▼ |
| Fesoterodine fumarate | 212 | 1,876 | £180 | +437.5% ▲ |
| Baclofen | 211 | 35.7K | £889 | +5.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.